Search research articles
Contact Us
Filters
Showing results (161-170 of 186) with videos related to
Page
of 19
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology
|
April 1, 1985
Normolipemic activities of acrylophenone derivatives with antimicrotubular properties
J M Bard, M Luyckx, C Brunet, et al.
Acta Neuropathologica
|
March 25, 1999
Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration
T Bussière, P R Hof, C Mailliot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 1, 1991
Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder?
D Leys, J P Pruvo, M Parent, et al.
Free Radical Research Communications
|
January 1, 1991
Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains
I Ceballos, F Javoy-Agid, A Delacourte, et al.
Neuroscience Letters
|
May 18, 1999
Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE
C Soulié, V Mitchell, L Dupont-Wallois, et al.
Arzneimittel-Forschung
|
January 1, 1986
Chemical and pharmacological studies of 2-(amino-methyl)acrylophenones
I Lesieur, D Lesieur, C Lespagnol, et al.
Neurobiology of Disease
|
January 1, 1997
ApoE synthesis in human neuroblastoma cells
L Dupont-Wallois, C Soulié, N Sergeant, et al.
Journal of Neuropathology and Experimental Neurology
|
February 1, 1996
Specific pathological Tau protein variants characterize Pick's disease
A Delacourte, Y Robitaille, N Sergeant, et al.
Free Radical Research Communications
|
January 1, 1991
Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome
I Ceballos, A Nicole, P Briand, et al.
Neuroscience Letters
|
May 9, 1997
Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease
F Wavrant-DeVrièze, J Pérez-Tur, J C Lambert, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 186) with videos related to
Sort By:
Page
of 19
Methods and Findings in Experimental and Clinical Pharmacology
|
April 1, 1985
Normolipemic activities of acrylophenone derivatives with antimicrotubular properties
J M Bard, M Luyckx, C Brunet, et al.
Acta Neuropathologica
|
March 25, 1999
Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration
T Bussière, P R Hof, C Mailliot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 1, 1991
Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder?
D Leys, J P Pruvo, M Parent, et al.
Free Radical Research Communications
|
January 1, 1991
Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains
I Ceballos, F Javoy-Agid, A Delacourte, et al.
Neuroscience Letters
|
May 18, 1999
Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE
C Soulié, V Mitchell, L Dupont-Wallois, et al.
Arzneimittel-Forschung
|
January 1, 1986
Chemical and pharmacological studies of 2-(amino-methyl)acrylophenones
I Lesieur, D Lesieur, C Lespagnol, et al.
Neurobiology of Disease
|
January 1, 1997
ApoE synthesis in human neuroblastoma cells
L Dupont-Wallois, C Soulié, N Sergeant, et al.
Journal of Neuropathology and Experimental Neurology
|
February 1, 1996
Specific pathological Tau protein variants characterize Pick's disease
A Delacourte, Y Robitaille, N Sergeant, et al.
Free Radical Research Communications
|
January 1, 1991
Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome
I Ceballos, A Nicole, P Briand, et al.
Neuroscience Letters
|
May 9, 1997
Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease
F Wavrant-DeVrièze, J Pérez-Tur, J C Lambert, et al.
Page
of 19